Bayer developed a fluoroquinolone antibiotic targeted at treatment for respiratory tract infections such as bronchitis, sinusitis and pneumonia. The drug will strengthen Bayer’s leading position in antibiotics.

Origin Brand Consultants worked with Bayer to develop the brand name Avelox.